HEADER TRANSFERASE 07-AUG-02 1MDO TITLE CRYSTAL STRUCTURE OF ARNB AMINOTRANSFERASE WITH PYRIDOMINE 5' TITLE 2 PHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARNB AMINOTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PUTATIVE DEGT/DNRJ/ERYC1/STRS FAMILY; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SALMONELLA TYPHIMURIUM; SOURCE 3 ORGANISM_TAXID: 602; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TYPE 1 AMINOTRANSFERASE FOLD, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.W.NOLAND,J.M.NEWMAN,J.HENDLE,J.BADGER,J.A.CHRISTOPHER,J.TRESSER, AUTHOR 2 M.D.BUCHANAN,T.WRIGHT,M.E.RUTTER,W.E.SANDERSON,H.-J.MULLER- AUTHOR 3 DIECKMANN,K.GAJIWALA,J.M.SAUDER,S.G.BUCHANAN REVDAT 5 26-DEC-18 1MDO 1 AUTHOR REVDAT 4 13-JUL-11 1MDO 1 VERSN REVDAT 3 24-FEB-09 1MDO 1 VERSN REVDAT 2 30-AUG-05 1MDO 1 REMARK REVDAT 1 11-DEC-02 1MDO 0 JRNL AUTH B.W.NOLAND,J.M.NEWMAN,J.HENDLE,J.BADGER,J.A.CHRISTOPHER, JRNL AUTH 2 J.TRESSER,M.D.BUCHANAN,T.WRIGHT,M.E.RUTTER,W.E.SANDERSON, JRNL AUTH 3 H.-J.MULLER-DIECKMANN,K.GAJIWALA,S.G.BUCHANAN JRNL TITL STRUCTURAL STUDIES OF SALMONELLA TYPHIMURIUM ARNB (PMRH) JRNL TITL 2 AMINOTRANSFERASE: A 4-AMINO-4-DEOXY-L-ARABINOSE JRNL TITL 3 LIPOPOLYSACCHARIDE MODIFYING ENZYME JRNL REF STRUCTURE V. 10 1569 2002 JRNL REFN ISSN 0969-2126 JRNL PMID 12429098 JRNL DOI 10.1016/S0969-2126(02)00879-1 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.BADGER,J.M.SAUDER,J.M.ADAMS,S.ANTONYSAMY,K.BAIN, REMARK 1 AUTH 2 M.G.BERGSEID,S.G.BUCHANAN,M.D.BUCHANAN,Y.BATIYENKO, REMARK 1 AUTH 3 J.A.CHRISTOPHER,S.EMTAGE,A.EROSHKINA,I.FEIL,E.B.FURLONG, REMARK 1 AUTH 4 K.S.GAJIWALA,X.GAO,D.HE,J.HENDLE,A.HUBER,K.HODA,P.KEARINS, REMARK 1 AUTH 5 C.KISSINGER,B.LAUBERT,H.A.LEWIS,J.LIN,K.LOOMIS,D.LORIMER, REMARK 1 AUTH 6 G.LOUIE,M.MALETIC,C.D.MARSH,I.MILLER,J.MOLINARI, REMARK 1 AUTH 7 H.J.MULLER-DIECKMANN,J.M.NEWMAN,B.W.NOLAND,B.PAGARIGAN, REMARK 1 AUTH 8 F.PARK,T.S.PEAT,K.W.POST,S.RADOJICIC,A.RAMOS,R.ROMERO, REMARK 1 AUTH 9 M.E.RUTTER,W.E.SANDERSON,K.D.SCHWINN,J.TRESSER,J.WINHOVEN, REMARK 1 AUTH10 T.A.WRIGHT,L.WU,J.XU,T.J.R.HARRIS REMARK 1 TITL STRUCTURAL ANALYSIS OF A SET OF PROTEINS RESULTING FROM A REMARK 1 TITL 2 BACTERIAL GENOMICS PROJECT REMARK 1 REF PROTEINS V. 60 787 2005 REMARK 1 REFN ISSN 0887-3585 REMARK 1 PMID 16021622 REMARK 1 DOI 10.1002/PROT.20541 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 60130 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2907 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2713 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 477 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MDO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-AUG-02. REMARK 100 THE DEPOSITION ID IS D_1000016837. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60130 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 29.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, PEG 10000, BETA REMARK 280 -MERCAPTOETHANOL, PH 5.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.29250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.57700 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.57700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 96.43875 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.57700 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.57700 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.14625 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.57700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.57700 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 96.43875 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.57700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.57700 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.14625 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 64.29250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 GLY A 4 REMARK 465 LYS A 5 REMARK 465 MSE A 6 REMARK 465 MSE A 7 REMARK 465 SER A 8 REMARK 465 ALA A 221 REMARK 465 TRP A 222 REMARK 465 ASP A 223 REMARK 465 ARG A 224 REMARK 465 GLN A 225 REMARK 465 SER A 226 REMARK 465 GLY A 227 REMARK 465 GLY A 228 REMARK 465 ARG A 229 REMARK 465 ALA A 230 REMARK 465 PRO A 231 REMARK 465 GLN A 385 REMARK 465 GLY A 386 REMARK 465 SER A 387 REMARK 465 HIS A 388 REMARK 465 HIS A 389 REMARK 465 HIS A 390 REMARK 465 HIS A 391 REMARK 465 HIS A 392 REMARK 465 HIS A 393 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 9 CB CG OD1 OD2 REMARK 470 ARG A 15 NE CZ NH1 NH2 REMARK 470 GLU A 78 CG CD OE1 OE2 REMARK 470 GLU A 118 CG CD OE1 OE2 REMARK 470 GLU A 151 CG CD OE1 OE2 REMARK 470 ARG A 172 CD NE CZ NH1 NH2 REMARK 470 ARG A 177 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 204 CD OE1 NE2 REMARK 470 GLN A 232 CG CD OE1 NE2 REMARK 470 HIS A 274 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 275 CG CD OE1 NE2 REMARK 470 ASP A 279 CB CG OD1 OD2 REMARK 470 GLN A 283 CG CD OE1 NE2 REMARK 470 GLU A 291 OE1 OE2 REMARK 470 ARG A 307 CZ NH1 NH2 REMARK 470 LYS A 320 CE NZ REMARK 470 THR A 321 OG1 CG2 REMARK 470 LYS A 322 CD CE NZ REMARK 470 GLU A 356 CG CD OE1 OE2 REMARK 470 GLN A 381 CD OE1 NE2 REMARK 470 ILE A 382 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 107 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 36 -166.53 -100.69 REMARK 500 ALA A 193 -61.07 79.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PMP A 394 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MDX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ARNB TRANSFERASE WITH PYRIDOXAL 5' PHOSPHATE REMARK 900 RELATED ID: 1MDZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ARNB AMINOTRANSFERASE WITH CYLOSERINE REMARK 900 PYRIDOXAL 5' PHOSPHATE DBREF 1MDO A 1 385 UNP Q8ZNF3 ARNB_SALTY 1 385 SEQADV 1MDO MSE A 1 UNP Q8ZNF3 MET 1 MODIFIED RESIDUE SEQADV 1MDO MSE A 6 UNP Q8ZNF3 MET 6 MODIFIED RESIDUE SEQADV 1MDO MSE A 7 UNP Q8ZNF3 MET 7 MODIFIED RESIDUE SEQADV 1MDO MSE A 18 UNP Q8ZNF3 MET 18 MODIFIED RESIDUE SEQADV 1MDO MSE A 67 UNP Q8ZNF3 MET 67 MODIFIED RESIDUE SEQADV 1MDO MSE A 72 UNP Q8ZNF3 MET 72 MODIFIED RESIDUE SEQADV 1MDO MSE A 87 UNP Q8ZNF3 MET 87 MODIFIED RESIDUE SEQADV 1MDO MSE A 95 UNP Q8ZNF3 MET 95 MODIFIED RESIDUE SEQADV 1MDO MSE A 105 UNP Q8ZNF3 MET 105 MODIFIED RESIDUE SEQADV 1MDO MSE A 114 UNP Q8ZNF3 MET 114 MODIFIED RESIDUE SEQADV 1MDO MSE A 277 UNP Q8ZNF3 MET 277 MODIFIED RESIDUE SEQADV 1MDO MSE A 316 UNP Q8ZNF3 MET 316 MODIFIED RESIDUE SEQADV 1MDO MSE A 367 UNP Q8ZNF3 MET 367 MODIFIED RESIDUE SEQADV 1MDO GLY A 386 UNP Q8ZNF3 EXPRESSION TAG SEQADV 1MDO SER A 387 UNP Q8ZNF3 EXPRESSION TAG SEQADV 1MDO HIS A 388 UNP Q8ZNF3 EXPRESSION TAG SEQADV 1MDO HIS A 389 UNP Q8ZNF3 EXPRESSION TAG SEQADV 1MDO HIS A 390 UNP Q8ZNF3 EXPRESSION TAG SEQADV 1MDO HIS A 391 UNP Q8ZNF3 EXPRESSION TAG SEQADV 1MDO HIS A 392 UNP Q8ZNF3 EXPRESSION TAG SEQADV 1MDO HIS A 393 UNP Q8ZNF3 EXPRESSION TAG SEQRES 1 A 393 MSE ALA GLU GLY LYS MSE MSE SER ASP PHE LEU PRO PHE SEQRES 2 A 393 SER ARG PRO ALA MSE GLY ALA GLU GLU LEU ALA ALA VAL SEQRES 3 A 393 LYS THR VAL LEU ASP SER GLY TRP ILE THR THR GLY PRO SEQRES 4 A 393 LYS ASN GLN GLU LEU GLU ALA ALA PHE CYS ARG LEU THR SEQRES 5 A 393 GLY ASN GLN TYR ALA VAL ALA VAL SER SER ALA THR ALA SEQRES 6 A 393 GLY MSE HIS ILE ALA LEU MSE ALA LEU GLY ILE GLY GLU SEQRES 7 A 393 GLY ASP GLU VAL ILE THR PRO SER MSE THR TRP VAL SER SEQRES 8 A 393 THR LEU ASN MSE ILE VAL LEU LEU GLY ALA ASN PRO VAL SEQRES 9 A 393 MSE VAL ASP VAL ASP ARG ASP THR LEU MSE VAL THR PRO SEQRES 10 A 393 GLU HIS ILE GLU ALA ALA ILE THR PRO GLN THR LYS ALA SEQRES 11 A 393 ILE ILE PRO VAL HIS TYR ALA GLY ALA PRO ALA ASP LEU SEQRES 12 A 393 ASP ALA ILE TYR ALA LEU GLY GLU ARG TYR GLY ILE PRO SEQRES 13 A 393 VAL ILE GLU ASP ALA ALA HIS ALA THR GLY THR SER TYR SEQRES 14 A 393 LYS GLY ARG HIS ILE GLY ALA ARG GLY THR ALA ILE PHE SEQRES 15 A 393 SER PHE HIS ALA ILE LYS ASN ILE THR CYS ALA GLU GLY SEQRES 16 A 393 GLY ILE VAL VAL THR ASP ASN PRO GLN PHE ALA ASP LYS SEQRES 17 A 393 LEU ARG SER LEU LYS PHE HIS GLY LEU GLY VAL ASP ALA SEQRES 18 A 393 TRP ASP ARG GLN SER GLY GLY ARG ALA PRO GLN ALA GLU SEQRES 19 A 393 VAL LEU ALA PRO GLY TYR LYS TYR ASN LEU PRO ASP LEU SEQRES 20 A 393 ASN ALA ALA ILE ALA LEU ALA GLN LEU GLN LYS LEU ASP SEQRES 21 A 393 ALA LEU ASN ALA ARG ARG ALA ALA ILE ALA ALA GLN TYR SEQRES 22 A 393 HIS GLN ALA MSE ALA ASP LEU PRO PHE GLN PRO LEU SER SEQRES 23 A 393 LEU PRO SER TRP GLU HIS ILE HIS ALA TRP HIS LEU PHE SEQRES 24 A 393 ILE ILE ARG VAL ASP GLU ALA ARG CYS GLY ILE THR ARG SEQRES 25 A 393 ASP ALA LEU MSE ALA SER LEU LYS THR LYS GLY ILE GLY SEQRES 26 A 393 THR GLY LEU HIS PHE ARG ALA ALA HIS THR GLN LYS TYR SEQRES 27 A 393 TYR ARG GLU ARG PHE PRO THR LEU THR LEU PRO ASP THR SEQRES 28 A 393 GLU TRP ASN SER GLU ARG ILE CYS SER LEU PRO LEU PHE SEQRES 29 A 393 PRO ASP MSE THR GLU SER ASP PHE ASP ARG VAL ILE THR SEQRES 30 A 393 ALA LEU HIS GLN ILE ALA GLY GLN GLY SER HIS HIS HIS SEQRES 31 A 393 HIS HIS HIS MODRES 1MDO MSE A 18 MET SELENOMETHIONINE MODRES 1MDO MSE A 67 MET SELENOMETHIONINE MODRES 1MDO MSE A 72 MET SELENOMETHIONINE MODRES 1MDO MSE A 87 MET SELENOMETHIONINE MODRES 1MDO MSE A 95 MET SELENOMETHIONINE MODRES 1MDO MSE A 105 MET SELENOMETHIONINE MODRES 1MDO MSE A 114 MET SELENOMETHIONINE MODRES 1MDO MSE A 277 MET SELENOMETHIONINE MODRES 1MDO MSE A 316 MET SELENOMETHIONINE MODRES 1MDO MSE A 367 MET SELENOMETHIONINE HET MSE A 18 8 HET MSE A 67 8 HET MSE A 72 8 HET MSE A 87 12 HET MSE A 95 8 HET MSE A 105 8 HET MSE A 114 8 HET MSE A 277 8 HET MSE A 316 8 HET MSE A 367 8 HET PMP A 394 16 HETNAM MSE SELENOMETHIONINE HETNAM PMP 4'-DEOXY-4'-AMINOPYRIDOXAL-5'-PHOSPHATE HETSYN PMP PYRIDOXAMINE-5'-PHOSPHATE FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 2 PMP C8 H13 N2 O5 P FORMUL 3 HOH *477(H2 O) HELIX 1 1 GLY A 19 GLY A 33 1 15 HELIX 2 2 GLY A 38 GLY A 53 1 16 HELIX 3 3 SER A 62 LEU A 74 1 13 HELIX 4 4 TRP A 89 LEU A 99 1 11 HELIX 5 5 THR A 116 ILE A 124 1 9 HELIX 6 6 HIS A 135 ALA A 139 5 5 HELIX 7 7 ASP A 142 GLY A 154 1 13 HELIX 8 8 ASN A 202 LYS A 213 1 12 HELIX 9 9 PRO A 245 LYS A 258 1 14 HELIX 10 10 LYS A 258 ASP A 279 1 22 HELIX 11 11 ASP A 304 GLY A 309 1 6 HELIX 12 12 THR A 311 LYS A 322 1 12 HELIX 13 13 ALA A 332 THR A 335 5 4 HELIX 14 14 GLN A 336 PHE A 343 1 8 HELIX 15 15 LEU A 348 GLU A 356 1 9 HELIX 16 16 THR A 368 GLY A 384 1 17 SHEET 1 A 4 TYR A 56 VAL A 60 0 SHEET 2 A 4 GLY A 196 THR A 200 -1 O VAL A 198 N VAL A 58 SHEET 3 A 4 THR A 179 SER A 183 -1 N PHE A 182 O ILE A 197 SHEET 4 A 4 GLU A 159 ASP A 160 1 N GLU A 159 O THR A 179 SHEET 1 B 3 ASN A 102 VAL A 106 0 SHEET 2 B 3 GLU A 81 PRO A 85 1 N VAL A 82 O VAL A 104 SHEET 3 B 3 THR A 128 ILE A 131 1 O LYS A 129 N GLU A 81 SHEET 1 C 3 ARG A 172 HIS A 173 0 SHEET 2 C 3 SER A 168 TYR A 169 -1 N TYR A 169 O ARG A 172 SHEET 3 C 3 HIS A 292 ILE A 293 -1 O ILE A 293 N SER A 168 SHEET 1 D 2 LEU A 217 GLY A 218 0 SHEET 2 D 2 GLU A 234 VAL A 235 -1 O GLU A 234 N GLY A 218 SHEET 1 E 3 GLN A 283 PRO A 284 0 SHEET 2 E 3 PHE A 299 ARG A 302 -1 O ARG A 302 N GLN A 283 SHEET 3 E 3 ILE A 358 LEU A 361 -1 O LEU A 361 N PHE A 299 LINK C ALA A 17 N MSE A 18 1555 1555 1.33 LINK C MSE A 18 N GLY A 19 1555 1555 1.32 LINK C GLY A 66 N MSE A 67 1555 1555 1.32 LINK C MSE A 67 N HIS A 68 1555 1555 1.34 LINK C LEU A 71 N MSE A 72 1555 1555 1.35 LINK C MSE A 72 N ALA A 73 1555 1555 1.35 LINK C SER A 86 N MSE A 87 1555 1555 1.35 LINK C MSE A 87 N THR A 88 1555 1555 1.33 LINK C ASN A 94 N MSE A 95 1555 1555 1.37 LINK C MSE A 95 N ILE A 96 1555 1555 1.34 LINK C VAL A 104 N MSE A 105 1555 1555 1.31 LINK C MSE A 105 N VAL A 106 1555 1555 1.33 LINK C LEU A 113 N MSE A 114 1555 1555 1.32 LINK C MSE A 114 N VAL A 115 1555 1555 1.32 LINK C ALA A 276 N MSE A 277 1555 1555 1.32 LINK C MSE A 277 N ALA A 278 1555 1555 1.33 LINK C LEU A 315 N MSE A 316 1555 1555 1.34 LINK C MSE A 316 N ALA A 317 1555 1555 1.33 LINK C ASP A 366 N MSE A 367 1555 1555 1.32 LINK C MSE A 367 N THR A 368 1555 1555 1.32 CISPEP 1 HIS A 329 PHE A 330 0 -0.36 SITE 1 AC1 17 SER A 62 ALA A 63 THR A 64 THR A 88 SITE 2 AC1 17 TRP A 89 ASP A 160 ALA A 162 HIS A 163 SITE 3 AC1 17 SER A 183 LYS A 188 LYS A 241 PHE A 330 SITE 4 AC1 17 HOH A 461 HOH A 833 HOH A 834 HOH A 836 SITE 5 AC1 17 HOH A 863 CRYST1 91.154 91.154 128.585 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010970 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010970 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007777 0.00000